BURLINGTON, Mass.--(BUSINESS WIRE)--Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
BURLINGTON, Mass.--(BUSINESS WIRE)--Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
